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Abstract
In this article, the video demonstrated is an example of a 76-year-old male patient who presented with recurrent intestinal
bleeding of unknown origin at the university hospital. Previously performed upper and lower gastrointestinal tract en-
doscopy did not reveal a bleeding lesion. Capsule endoscopy revealed small-bowel angiectasia that were treated by argon
plasma coagulation at subsequent balloon enteroscopy. This article is part of an expert video encyclopedia.
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Video Related to this Article
Techniques
Capsule endoscopy (CE) performed after bowel cleansing with
1–2 l of a polyethylene glycol electrolyte solution. The dosage
is split into two doses ingested the evening before and the
morning of the examination. Simethicone (approximately
80–120 mg) is offered before capsule ingestion.
Trans-anal balloon enteroscopy mandates a complete
bowel cleansing before conventional ileocolonoscopy.
Materials
• Capsule endoscope (PillCamTM SB2; Given Imaging EMEA,
Hamburg, Germany).
• Double-balloon enteroscope (working channel: 2.8 mm,
working length: 2300 mm, DBE EN-450T5; Fujinon/Fuji-
ﬁlm, Willich, Germany).
• APC catheter (ERBE, Tu¨bingen, Germany).
• Erbe VIO 200D (ERBE, Tu¨bingen, Germany), APC Precise
mode 2–4 or pulsed APC, effect 2 (20–25 W).
Endoscopic Procedures
A 76-year-old male patient was presented with recurrent in-
testinal bleeding of unknown origin at the university hospital.
Previously performed upper and lower gastrointestinal tract
endoscopy did not reveal an active bleeding lesion.
Concomitant medical condition comprised ischemic heart
disease, chronic obstructive pulmonary disease, and compen-
sated renal insufﬁciency. At esophago-gastro-duodenoscopy,
angiectasias (AEs) had been detected at the referring hospital
and were endoscopically treated with APC, but bleeding
recurred a few days later. CE was performed and multiple
AE in the stomach and the small bowel were demonstrated.
The lesions were treated by APC at subsequent balloon
enteroscopy.
AEs is the most frequent reason for small-bowel bleeding
in Europe and the USA. Although the terms angiodysplasia,
AE, or arteriovenous/vascular malformation are used syn-
onymously, telangiectasia is commonly used for systemic or
congenital diseases. All share a similar morphology of ectatic
and thin-walled vessels that may feature an arteriovenous
communication due to an insufﬁciency of the precapillary
sphincter. In contrast to sporadic AE, hereditary hemorrhagic
teleangiectasia (Rendu–Osler–Weber syndrome) is a rare
autosomal dominant vascular disorder that is accompanied by
an alteration of the angiogenetic transforming growth factor-b
resulting in arteriovenous malformations of skin, mucosa, and
viscera (lung, liver, and brain).
The etiology of sporadic AE remains unclear. Possibly,
pathogenetic factors contributing to the formation of AE are
vascular endothelial growth factor (VEGF)-related disorders of
angiogenesis, age-related vessel degeneration, and high intes-
tinal wall tension (e.g., caused by chronic constipation)
causing chronic obstruction of submucosal veins with con-
secutive precapillary dilatation. Risk factors for gastrointestinal
bleeding from AE have been identiﬁed, namely autoimmune
disorders, liver cirrhosis, renal failure, ischemic heart disease,
aortic stenosis, and treatment with anticoagulants. The asso-
ciation of aortic stenosis and gastrointestinal hemorrhage
from AE (Heyde’s syndrome) is most likely due to an acquired
deﬁciency of the ‘von Willebrand’ factor (vWF) caused by a
mechanical disruption of the vWF monomer at its turbulent
passage through the obstructed aortic valve.
Detection of gastric AE has a high prevalence (approxi-
mately two-third of patients) of concomitant small bowel
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affection, and colonic AE comes along with small bowel le-
sions in approximately 50% of cases. Therefore, CE should be
considered in all patients with symptomatic lesions of the
upper or lower gastrointestinal tract.
Treatment options include endoscopic techniques (APC,
injection therapy: suprarenin, ﬁbrin glue, and through-the-
scope clip application) and surgery. Thalidomide is an in-
hibitor of angiogenesis by suppressing VEGF expression and is
an effective medical therapeutic option for recurrent gastro-
intestinal bleedings from vascular malformations.
Despite application of optimal treatment there is a high
risk of recurrent bleeding during long-term follow up.
Key Learning Points/Tips and Tricks
• AE is the most important source of small bowel bleeding.
• Endoscopy is the reference standard to detect AE.
• CE is most often used for diagnosis of small bowel
bleeding, and balloon enteroscopy is the ﬁrst choice in
treating AE (e.g., APC).
Complications and Risk Factors
• Capsule retention rate is very low (less than 1%) in diag-
nostic investigations of small-bowel bleeding. Risk factors
for capsule retention are Crohn’s disease, prolonged use of
non steroidal anti inﬂammatory drugs, and prior abdom-
inal surgery.
• Therapeutic balloon enteroscopy harbors a low risk of
perforation.
Alternatives
• Computed tomography (CT) and CT angiography may
clearly delineate active bleeding from the small bowel and
offer embolization, but is rarely diagnostic in small-bowel
lesions that had previously bled.
• Surgical resection of AE that are restricted to a circum-
scribed bowel segment is a therapeutic option in the
second line.
Scripted Voiceover
Time
(min:sec)
Voiceover text
0:00 This is a 76-year-old male patient who presented with
recurrent intestinal bleeding of unknown origin.
0:10 A small angiectasia is demarcated at capsule endoscopy in
the gastric antrum.
0:23 There are multiple angiectasias of the small bowel
detected by capsule endoscopy. Therefore, balloon
enteroscopy was scheduled to treat the lesions.
0:56 Double balloon enteroscopy identiﬁes the small bowel
angiectasias; the lesion may be a ﬂat red spot of only a
few millimeters or it may measure up to 1 or 2 cm.
1:24 With use of a speciﬁc probe, argon plasma coagulation
can easily be applied at the lesion. A stable position of
the endoscope is crucial for targeted treatment. The use
of low energy outputs at argon plasma coagulation
(APC) also helps to minimize the risk of perforation in
thin-walled intestinal areas such as the small bowel.
2:09 With increase of size, angiectasias are suspected to harbor
a high potential of bleeding, and elevated lesions are
often said to be exceptionally prone to bleed.
2:36 At some positions of the balloon enteroscope or the lesion
it might be difﬁcult to adjust the optimal distance of the
APC probe from the bowel mucosa for the argon beam
to trigger ﬁring. The mode ‘Precise APC’ offers distance
independent application of APC.
2:59 Beside devices that offer an axial argon plasma beam,
there are APC probes available featuring side-ﬁring. This
might help in some endoscopic positions to improve
targeting the lesion. Flexible APC probes for endoscopic
use are available as reusable or disposable devices.
3:25 To improve stability of the position, intravenous
application of butylscopolamine or glucagon, might be
of some help by signiﬁcantly reducing bowel motility.
Studies have demonstrated that bleeding from
angiectasias in the small bowel can be effectively treated
with APC using balloon enteroscopy, and long-term
follow-up data show an increase in hemoglobin levels
and reduced blood transfusion requirements after
endoscopic therapy. Nevertheless recurrent bleeding
might be an issue in some patients in whom endoscopic
treatment needs to be repeated. Prospective data
indicate that medical treatment with thalidomide might
be an additional option for recurrently bleeding patients.
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